Clinical Trials in Pittsburgh

Showing 10301-10320 of 21,047 trials

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

NCT04415606

QuikClot Control+ Hemostatic Dressing (QuikClot+) is indicated for temporary control of internal organ space bleeding for patients displaying Class III or Class IV Bleeding. It may also be used for control of severely bleeding wounds such as surgical wounds and traumatic injuries. QuikClot Control+ is also indicated for temporary control of mild to moderate bleeding in cardiac surgical procedures. QuikClot Control+ is also indicated for use to control bleeding from bone surface following sternotomy.

Hemostasis

Z-Medica266 participantsStarted Jun 2020

Aurora, Colorado, United States • Atlanta, Georgia, United States • Pocatello, Idaho, United States +4 more locations

COMPLETED< 1 mile

NSABP Patient Registry and Biospecimen Profiling Repository

NCT01793805

This is a study to collect and analyze tissue specimens from metastatic colorectal cancer (mCRC) patients for the development of a molecularly profiled tissue repository for the primary purpose of maintaining a patient registry for future clinical trials based on the molecular profile of the tumors. The main purpose of testing these tissue specimens is to identify genetic alterations or biomarkers associated with colorectal cancer such that if new agent(s) become available, particularly those that target these genetic alterations/biomarkers, participants may be offered the opportunity to take part in a National Surgical Adjuvant Breast and Bowel Project (NSABP) treatment protocol.

Colorectal Cancer

NSABP Foundation Inc3,232 participantsStarted Feb 2013

Duarte, California, United States • San Diego, California, United States • Vallejo, California, United States +43 more locations

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

NSABP Patient Registry and Biospecimen Profiling Repository

Find Trials by Condition in Pittsburgh

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure

A Study of Oral Contraception Under Simulated OTC Conditions

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Half-normal Saline in Atrial Fibrillation Ablation

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Neuroimaging Biomarker for Seizures

Parents Advancing Toddler Health

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers